Bipolar_disorder - Articles | CARLAT PUBLISHING

Thyroid Augmentation in Bipolar Disorder

April 5, 2022

Tammas Kelly, MD. Clinical Assistant Professor of Psychiatry at the Jacobs School of Medicine and Clinical Associate Professor of Psychiatry at the George Washington University School of Medicine. Author of The Art and Science of Thyroid Supplementation for the Treatment of Bipolar Depression. Dr. Kelly has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A primer on the role of thyroid augmentation in bipolar depression, including dosing tips, side effects, interactions, and when and if to perform labs. With Tammas Kelly, MD.

Lumateperone in Bipolar Depression

January 31, 2022

John C. Raiss, MD.

John C. Raiss, MD. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In December 2021, the FDA approved lumateperone (Caplyta) for bipolar I and II depression, and here we report on one of the trials that led to that approval.

RESEARCH UPDATE

A Novel Treatment for Methamphetamine Use Disorder

January 31, 2022

David A. Moltz, MD.

David A. Moltz, MD. Dr. Moltz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With so few pharmacologic options for methamphetamine use disorder, a large trial from The New England Journal of Medicine suggest bupropion and naltrexone are worth exploring.

Quetiapine in Bipolar With OCD

January 4, 2022

Richard Moldawsky, MD.

Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

OCD and bipolar disorder often occur together, and this randomized controlled trial looks at whether quetiapine can treat this comorbidity.

How to Diagnose Bipolar Disorder

November 5, 2021

Gordon Parker, MD, PhD, DSc.

Gordon Parker, MD, PhD, DSc. Scientia Professor of psychiatry at the University of New South Wales. In 2002 he founded the Black Dog Institute, a clinical research center for mood disorders. Dr. Parker’s research has focused on the phenomenology and diagnosis of depression and bipolar disorder. Dr. Parker has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Gordon Parker takes on the DSM and offers up a practical approach to diagnosing bipolar disorder. Included is a new self-rated scale that Dr. Parker developed to separate normal good moods from hypomania.

How to Treat ADHD in Bipolar Disorder

November 5, 2021

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Are stimulants risky in bipolar disorder? And which is safer – methylphenidate or amphetamine? Chris Aiken, MD, lays out a practical approach to the overlap of bipolar disorder and ADHD.

EXPERT Q&A

Assessing Bipolar Disorder in Children and Adolescents

October 18, 2021

Anna Van Meter, MD

Anna Van Meter, MD

Assistant professor, Institute of Behavioral Science at the Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY. Assistant professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Dr. Van Meter has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Most of us need more clarity to better differentiate bipolar disorder from other problems such as ADHD with irritability or other mood problems. In this interview, Dr Ann Van Meter offers a simple methodology for making better predictions about the risk of bipolar illness in children and adolescents based on risk factors and symptomatology.

How to Diagnose ADHD in Bipolar Disorder

September 28, 2021

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Most patients with bipolar disorder have cognitive complaints, but it’s a mistake to diagnose them all with ADHD, and a mistake to miss the genuine ADHD-bipolar comorbidity as well. Inside, a step-by-step guide to teasing apart the diagnoses.

Maintenance Pharmacotherapy of Bipolar Disorder: How Long Is Long Enough?

May 4, 2021

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Textbooks tell us that patients with bipolar I disorder need to take mood stabilizers for life. But what are the real risks of stopping these medications? A new meta-analysis provides some clarity.

Antidepressants Harm Some With Bipolar Depression

March 26, 2021

Chris Aiken, MD.

Chris Aiken, MD. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This new study is the first placebo-controlled trial to examine the long-term effects of an SSRI in bipolar disorder.